CRISPR and Genetic Engineering: How Gene Editing Works and Why It Matters

Added:

Bioconservatism and the Disability Rights Critique

While proponents frame CRISPR as a revolutionary tool for curing diseases, a significant counterpoint emerges from bioconservatism and disability studies. Bioconservative theorists argue that genetic enhancement threatens human dignity and risks altering human nature, potentially undermining our shared moral status. They advocate for preserving natural biological limits, warning against a hubristic attempt to master human evolution. Parallel to this, the disability rights perspective raises the 'expressivist objection,' arguing that using gene editing to eliminate specific genetic variations devalues the lives of living disabled individuals. This critique suggests that genetic diversity, including disability, is a natural facet of human variation. Rather than 'fixing' individuals to fit a rigid biological norm, they argue that society should focus on social inclusion, accessibility, and dismantling systemic barriers. Ultimately, this counterpoint challenges the assumption that genetic 'perfection' is a universally desirable goal, warning that CRISPR could inadvertently foster a new era of consumer-driven eugenics that worsens social inequalities.

Structure of DNA and RNA: Understanding nucleotides, base-pairing rules (A-T, C-G), and the double helix structure.
The Central Dogma of Molecular Biology: How genetic information flows from DNA to RNA to functional proteins.
Basic genetics and mutations: Knowing how alterations in DNA sequences can lead to genetic disorders or phenotypical changes.
The immune system of bacteria: A basic understanding of how bacteria defend themselves against viral infections (bacteriophages).
Somatic vs. Germline Editing: Exploring the technical and ethical differences between editing non-reproductive cells versus heritable reproductive cells.
Next-generation gene editing tools: Investigating advanced modifications of CRISPR like Base Editing and Prime Editing that do not require double-stranded DNA breaks.
Clinical trials and therapeutic pipelines: Studying current FDA-approved CRISPR therapies (such as those for sickle cell anemia) and active clinical trials.
Global bioethics and regulation: Examining the international policies, declarations, and governance frameworks that regulate genetic modification in humans and agriculture.
30.5M views640.8Klikes16:04@kurzgesagtOriginal Release: 2016-08-10

CRISPR is a revolutionary gene-editing technology derived from bacterial immune systems that allows scientists to make precise modifications to DNA with unprecedented ease and affordability, potentially enabling cures for genetic diseases, cancer treatments, and even addressing aging, though it also raises significant ethical concerns about human enhancement and genetic modification.